XERIS BIOPHARMA HOLDINGS INC (XERS) Stock Earnings Estimates

USA • Nasdaq • NASDAQ:XERS • US98422E1038

7.01 USD
+0.1 (+1.45%)
At close: Feb 6, 2026
7.01 USD
0 (0%)
After Hours: 2/6/2026, 4:30:02 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
XERS revenue by date.XERS revenue by date.
110.2M
122.18%
163.914M
48.74%
203.07M
23.89%
293.98M
44.77%
375.46M
27.72%
444.27M
18.33%
506.3M
13.96%
582.52M
15.05%
615.47M
5.66%
533.05M
-13.39%
582.01M
9.18%
EBITDA
YoY % growth
XERS ebitda by date.XERS ebitda by date.
-59.56M
43.07%
-31.68M
46.81%
-21.576M
31.89%
56.049M
359.77%
66.096M
17.93%
93.075M
40.82%
162.91M
75.03%
184.86M
13.47%
212.66M
15.04%
N/AN/A
EBIT
YoY % growth
XERS ebit by date.XERS ebit by date.
-71.8M
32.58%
-44.01M
38.70%
-33.646M
23.55%
18.523M
155.05%
55.243M
198.24%
94.962M
71.90%
134.35M
41.48%
210.17M
56.43%
282.74M
34.53%
N/AN/A
Operating Margin
XERS operating margin by date.XERS operating margin by date.
-65.15%-26.85%-16.57%6.30%14.71%21.37%26.54%36.08%45.94%N/AN/A
EPS
YoY % growth
XERS eps by date.XERS eps by date.
-0.70
53.95%
-0.45
35.71%
-0.38
15.56%
-0.04
88.59%
0.19
527.06%
0.36
96.14%
0.57
57.30%
0.94
64.29%
1.13
20.65%
N/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
0.04
249.60%
0.01
114.45%
0.04
530.95%
0.060.08
77.84%
0.02
135.29%
0.02
-52.66%
0.03
-50.41%
0.04
-48.88%
Revenue
Q2Q % growth
83.987M
39.75%
85.374M
42.01%
95.03M
32.84%
101.93M
37.04%
107.07M
27.48%
97.41M
14.10%
98.328M
3.47%
99.756M
-2.13%
102.61M
-4.17%
EBITDA
Q2Q % growth
20.553M
49.49%
14.076M
21,755.38%
13.566M
28.67%
15.198M
-4.06%
15.3M
-25.56%
19.482M
38.41%
19.278M
42.11%
21.42M
40.94%
22.848M
49.33%
EBIT
Q2Q % growth
10.261M
511.14%
6.562M
312.36%
12.648M
182.20%
16.456M
144.48%
19.448M
89.53%
9.69M
47.67%
9.486M
-25.00%
11.628M
-29.34%
13.056M
-32.87%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
0.00
100.00%
0.000.00-100.00%
Q2 2025
Q2Q % growth
-0.01
90.00%
-0.030.0264.35%
Q1 2025
Q2Q % growth
-0.06
57.14%
-0.05-0.01-10.30%
Q4 2024
Q2Q % growth
-0.03
70.00%
-0.060.0353.56%
Q3 2024
Q2Q % growth
-0.11
-22.22%
-0.09-0.02-19.83%
Q2 2024
Q2Q % growth
-0.10
28.57%
-0.110.018.09%
Q1 2024
Q2Q % growth
-0.14
-16.67%
-0.12-0.02-17.64%
Q4 2023
Q2Q % growth
-0.10 -0.100.00-0.04%
Q3 2023
Q2Q % growth
-0.09
43.75%
-0.120.0323.94%
Q2 2023
Q2Q % growth
-0.14
26.32%
-0.13-0.01-7.65%
Q1 2023
Q2Q % growth
-0.12
52.00%
-0.170.0529.76%
Q4 2022
Q2Q % growth
-0.10
76.19%
-0.160.0637.75%
Q3 2022
Q2Q % growth
-0.16
58.97%
-0.170.014.93%
Q2 2022
Q2Q % growth
-0.19
53.66%
-0.230.0419.01%
Q1 2022
Q2Q % growth
-0.25
16.67%
-0.260.013.50%
Q4 2021
Q2Q % growth
-0.42
-2.44%
-0.25-0.17-68.76%
Q3 2021
Q2Q % growth
-0.39
-11.43%
-0.38-0.01-3.34%
Q2 2021
Q2Q % growth
-0.41
34.92%
-0.31-0.10-33.99%
Q1 2021
Q2Q % growth
-0.30
66.29%
-0.350.0514.13%
Q4 2020
Q2Q % growth
-0.41 -0.39-0.02-5.23%
Q3 2020
Q2Q % growth
-0.35 -0.530.1833.76%
Q2 2020
Q2Q % growth
-0.63 -0.750.1215.62%
Q1 2020
Q2Q % growth
-0.89 -0.910.021.74%
XERS Yearly EPS VS EstimatesXERS Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -2 -4
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
74.38M
37.06%
75.664M-1.284M-1.70%
Q2 2025
Q2Q % growth
71.539M
48.84%
65.867M5.672M8.61%
Q1 2025
Q2Q % growth
60.119M
47.94%
58.762M1.357M2.31%
Q4 2024
Q2Q % growth
60.099M
35.39%
59.266M833K1.41%
Q3 2024
Q2Q % growth
54.268M
12.31%
52.462M1.806M3.44%
Q2 2024
Q2Q % growth
48.065M
26.46%
46.727M1.338M2.86%
Q1 2024
Q2Q % growth
40.638M
22.42%
42.651M-2.013M-4.72%
Q4 2023
Q2Q % growth
44.39M
33.95%
44.423M-33K-0.07%
Q3 2023
Q2Q % growth
48.32M
62.53%
41.905M6.415M15.31%
Q2 2023
Q2Q % growth
38.008M
50.17%
35.534M2.474M6.96%
Q1 2023
Q2Q % growth
33.196M
50.41%
31.381M1.815M5.78%
Q4 2022
Q2Q % growth
33.14M
54.64%
31.659M1.481M4.68%
Q3 2022
Q2Q % growth
29.73M
168.81%
29.705M25K0.08%
Q2 2022
Q2Q % growth
25.31M
184.06%
26.042M-732K-2.81%
Q1 2022
Q2Q % growth
22.07M
169.15%
24.059M-1.989M-8.27%
Q4 2021
Q2Q % growth
21.43M
198.88%
19.276M2.154M11.17%
Q3 2021
Q2Q % growth
11.06M
17.04%
11.247M-187K-1.66%
Q2 2021
Q2Q % growth
8.91M
338.92%
9.735M-825K-8.47%
Q1 2021
Q2Q % growth
8.2M
358.10%
7.617M583K7.65%
Q4 2020
Q2Q % growth
7.17M 8.372M-1.202M-14.36%
Q3 2020
Q2Q % growth
9.45M 4.568M4.882M106.87%
Q2 2020
Q2Q % growth
2.03M 1.899M131K6.90%
Q1 2020
Q2Q % growth
1.79M 1.457M333K22.86%
XERS Yearly Revenue VS EstimatesXERS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS15.79% 17.33% 1.92% -70%
Revenue1.21% 2.36% 0.28% 0.61%